Pfizer CME Restrictions: No Support For Education Firms, Caps Everywhere Else
Executive Summary
In response to the medical community's call for continuing medical education to receive financing from a variety of sources, Pfizer is limiting the percentage of funding it will provide for any one CME program
You may also be interested in...
Industry-Funded CME To Go Way Of Dinosaurs? ACCME Comments Lumber In
The pharmaceutical industry continues to retrench how it provides continuing medical education in response to public and congressional pressure, but firms are also marshalling for a fight against an outright ban
Industry-Funded CME To Go Way Of Dinosaurs? ACCME Comments Lumber In
The pharmaceutical industry continues to retrench how it provides continuing medical education in response to public and congressional pressure, but firms are also marshalling for a fight against an outright ban
CME Reforms Under PhRMA Code Increase The Influence Of ACCME
The Pharmaceutical Research and Manufacturers of America's revisions to its code on interactions with health care professionals will strengthen the influence of the Accreditation Council for Continuing Medical Education